Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2012 063 291.7 |
| 96 | EP file number | EAKZ | 17 20 6669.8 |
| 97 | EP publication number | EPN | 3318273 |
| 54 | Designation/title | TI | VERFAHREN ZUR ERHÖHUNG DER WIRKSAMKEIT EINER FOLR1-KREBSTHERAPIE |
| 51 | IPC main class | ICM
(ICMV) | A61K 39/395 (2006.01) |
| 22 | DE application date | DAT | Mar 30, 2012 |
| 96 | EP application date | EAT | Mar 30, 2012 |
| 43 | Date of first publication | OT | May 9, 2018 |
| Date of publication of grant | PET | Aug 21, 2019 |
| 71/73 | Applicant/owner | INH | ImmunoGen, Inc., Waltham, Mass., US |
| 72 | Inventor | IN | Carrigan, Christina, San Francisco, CA 94114, US; Whiteman, Kathleen R., Wilmington, MA 01887, US; PAYNE, Gillian, Waban, MA 02468, US; Ladd, Sharron, Gregory, MI 48137, US |
| Address for service | | Immunogen, Inc., WALTHAM, MA. 02451, US |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201161471007 P
Apr 1, 2011
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003318273A1
Searchable text:
EP000003318273A1
Original document:
EP000003318273B1
Searchable text:
EP000003318273B1 |
| 43 | Date of first publication | EVT | May 9, 2018 |
| Date of the first transfer into DPMAregister | EREGT | May 9, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | Dec 25, 2020
(Show all update days)(Hide all update days)- Dec 25, 2020; Nov 14, 2020; Aug 5, 2020; Jul 23, 2020; Aug 23, 2019; Aug 2, 2019; Aug 1, 2019; Apr 25, 2019; Jul 26, 2018
- Historical data not available for this/these date(s)
- May 9, 2018
- Date of the first transfer into DPMAregister
|
